Paragraph 41
The licence holder must cease importing or supplying a special medicinal product F1or EAMS medicinal product if the licence holder receives a notice in writing from the licensing authority directing that, from a date specified in the notice, a particular product or class of products may no longer be imported or supplied.
Annotations
Textual amendments
- F1
Words in Sch. 4 para. 41 inserted (15.4.2022) by The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022 (S.I. 2022/352), regs. 1(2), 14(9) (with reg. 19)